The global biguanide market is expected to show a considerable CAGR of more than 7.0% rate during the forecast period 2020-2026. Biguanide is a group of oral drugs used to treat type 2 diabetes. It works by reducing the amount of sugar released by the liver in the blood. In addition, it also improves the response of the body towards insulin. Metformin is the most common biguanide available in the global market. It is used as a first-line treatment for type 2 diabetes.
A full Report of Global Biguanide Market at https://www.omrglobal.com/industry-reports/biguanide-market
Increasing prevalence of type 2 diabetes cases all across the globe is the major factor for the increase in demand for the biguanide during the forecast period. As per the International Diabetes Federation (IDF), the global prevalence of diabetes in the age group of 20-79 years was 463 million in 2019. It is further estimated to reach 578 million by 2030. Moreover, annual global demand for Metformin drug is growing significantly owing to the increasing stature of the drug as a safe, proven, cost-effective, gold-standard drug of choice for treatment of diabetes. Moreover, the increasing demand for Metformin in combination with other drugs has encouraged major players in the global market. However, the presence of new alternatives for managing type 2 diabetes, and recall of the metformin are some of the major factors challenging market growth.
Request a Free Sample of Report on Global Biguanide Market @ https://www.omrglobal.com/request-sample/biguanide-market
Global Biguanide Market Segmentation
By Type
• Metformin IR (Immediate-Release)
• Metformin ER (Extended Release)
• Other Biguanide (Buformin, Phenformin, Chlorproguanil, Chloroguanide)
By Dosage Form
• Tablet
• Solution
Regional Analysis
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
Rest of the World
Company Profiles
• Aarti Drugs Ltd.
• Amneal Pharmaceuticals, Inc.
• Apotex Corp.
• AstraZeneca PLC
• BOEHRINGER Ingelheim International GmbH
• Bristol-Myers Squibb Co.
• Cadila Healthcare Ltd.
• Dr. Reddy's Laboratories, Inc.
• Eli Lilly and Co.
• Glenmark Pharmaceuticals, Ltd.
• Harman Finochem Ltd.
• Lupin, Ltd.
• Marksans Pharma Ltd.
• Merck & Co., Inc.
• Mylan N.V.
• Novartis AG
• Shandong Keyuan Pharmaceutical Co., Ltd.
• Teva Pharmaceutical Industries Ltd
• USV Pvt. Ltd.
• Vistin Pharma ASA
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/biguanide-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. AnuragTiwari
Email:
[email protected]
Contact no: +1 646-755-7667, +91 780-304-0404